CARI Health, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Holding
- Established
- 2021-10-06
- Employees
- 1
- Market Cap
- -
- Website
- http://www.carihealth.com
Clinical Trials
5
Active:0
Completed:1
Trial Phases
0 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Methadone Dose Monitoring With a Remote Medication Monitor
Not yet recruiting
- Conditions
- Methadone ToxicityMethadone OverdosePain, ChronicDrug Metabolism, Poor, CYP2D6-RelatedMetabolism Medication Toxicity
- Interventions
- Device: ISF Extraction Device 2Diagnostic Test: Measurement of Methadone in the Interstitial Fluid (ISF) before and after prescribed dose taken ex vivoDrug: Measurement of Methadone in the Interstitial Fluid before and after prescribed dose taken in vivo
- First Posted Date
- 2025-02-20
- Last Posted Date
- 2025-02-20
- Lead Sponsor
- Cari Health Inc.
- Target Recruit Count
- 30
- Registration Number
- NCT06837571
- Locations
- 🇺🇸
Synergy, Lemon Grove, California, United States
Assessing Concentrations of Methadone and Its Metabolites
- Conditions
- Opioid Use DisorderPain
- First Posted Date
- 2025-02-19
- Last Posted Date
- 2025-02-19
- Lead Sponsor
- Cari Health Inc.
- Target Recruit Count
- 20
- Registration Number
- NCT06835582
- Locations
- 🇺🇸
Synergy, Lemon Grove, California, United States
Assessing Dose Taken in Opioid Use Disordered Patients With an Electrochemical Sensor
Not yet recruiting
- Conditions
- Opioid Use DisorderAdherence, Medication
- Interventions
- Device: Remote Medication Monitor (RMM) - PrototypeDrug: Daily Methadone Dose
- First Posted Date
- 2023-08-21
- Last Posted Date
- 2023-08-21
- Lead Sponsor
- Cari Health Inc.
- Target Recruit Count
- 45
- Registration Number
- NCT05998876
Assessment of Methadone Dose Taken
Recruiting
- Conditions
- Methadone OverdoseDrug Metabolism, Poor, CYP2D6-RelatedMethadone ToxicityPain, ChronicMetabolism Medication Toxicity
- Interventions
- Diagnostic Test: Measurement of Methadone in the Interstitial Fluid (ISF) before and after prescribed dose taken ex vivoDrug: Measurement of Methadone in the Interstitial Fluid before and after prescribed dose taken in vivoDevice: ISF Extraction Device 2
- First Posted Date
- 2023-08-08
- Last Posted Date
- 2025-02-13
- Lead Sponsor
- Cari Health Inc.
- Target Recruit Count
- 30
- Registration Number
- NCT05981573
- Locations
- 🇺🇸
Synergy, Lemon Grove, California, United States
Assessment of Methadone and Buprenorphine in Interstitial Fluid
Completed
- Conditions
- Opioid Use Disorder
- First Posted Date
- 2022-09-19
- Last Posted Date
- 2023-06-28
- Lead Sponsor
- Cari Health Inc.
- Target Recruit Count
- 11
- Registration Number
- NCT05546229
- Locations
- 🇺🇸
Synergy San Diego, Lemon Grove, California, United States
News
No news found